Overview +

Celiac Disease Plasma | High-Quality Human Plasma from Celiac Disease Donors

Celiac Disease Plasma is collected from donors clinically diagnosed with celiac disease and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human celiac disease plasma supports research focused on biomarker discovery, immune response, metabolic profiling, and diagnostic and treatment development.

Product Features

  • Research Use Only (RUO)
  • Celiac disease plasma collected from clinically confirmed donors
  • Processed within one day of collection
  • IRB-approved protocols and informed consent
  • Custom aliquot volumes available upon request

Donor Metadata

  • Verified celiac disease diagnosis
  • Demographic data: age, sex assigned at birth, race/ethnicity
  • Donor-reported medications, allergies, and comorbidities
  • Additional celiac disease-specific metadata available

Applications

  • Biomarker discovery and validation
  • Cytokine and inflammation profiling
  • Metabolomics and proteomics studies
  • Therapeutic response research

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Celiac disease plasma is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.

Protocol and Documentation +

Document Type Technical Document Catalog Language
PDF > Leukopak Cryopreservation - -
PDF > Leukopak Thawing - -

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.